Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity
IG Motofei - Expert opinion on drug safety, 2022 - Taylor & Francis
ABSTRACT Introduction Immune checkpoint inhibitors (ICIs) are a revolutionary form of
immunotherapy in cancer. However, the percentage of patients responding to therapy is …
immunotherapy in cancer. However, the percentage of patients responding to therapy is …
Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity
IG Motofei - Expert opinion on drug safety, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Immune checkpoint inhibitors (ICIs) are a revolutionary form of immunotherapy
in cancer. However, the percentage of patients responding to therapy is relatively low, while …
in cancer. However, the percentage of patients responding to therapy is relatively low, while …
Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity.
IG Motofei - Expert Opinion on Drug Safety, 2021 - europepmc.org
Immune checkpoint inhibitors (ICIs) are a revolutionary form of immunotherapy in cancer.
However, the percentage of patients responding to therapy is relatively low, while adverse …
However, the percentage of patients responding to therapy is relatively low, while adverse …